SCHEMBL9699985

SCHEMBL9699985

O=C1CCCCC(=O)C(C(=O)O)N1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCL1 Q07820 1/20 0.34
CRBN Q96SW2 2/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
ALDH1A1 P00352 1/20 0.33
MAPT P10636 1/20 0.33
FKBP5 Q13451 1/20 0.33
GRIA2 P42262 1/20 0.33
ITGB3 P05106 1/20 0.32
ITGB2 P05107 1/20 0.32
ITGB1 P05556 1/20 0.32
ITGAV P06756 1/20 0.32
ITGA2B P08514 1/20 0.32
ITGA5 P08648 1/20 0.32
ITGB5 P18084 1/20 0.32
ITGAL P20701 1/20 0.32
KDM4E B2RXH2 1/20 0.31
POLB P06746 1/20 0.31
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
CA4 P22748 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9699954 0.98 KMT2A (0.33) MCL1CRBNL3MBTL1ALDH1A1MAPT
SCHEMBL9699920 0.98 KMT2A (0.33) MCL1CRBNL3MBTL1ALDH1A1MAPT
SCHEMBL380941 0.98 KMT2A (0.33) MCL1CRBNL3MBTL1ALDH1A1MAPT
SCHEMBL2274342 0.98 KMT2A (0.33) MCL1CRBNL3MBTL1ALDH1A1MAPT
SCHEMBL737201 0.87 ITGB3 (0.34) CRBNGRIA2ITGB3ITGB2ITGB1
SCHEMBL9172323 0.83 CRBN (0.33) MCL1CRBNL3MBTL1ALDH1A1MAPT
SCHEMBL8563469 0.76 ITGB3 (0.35) GRIA2ITGB3ITGB2ITGB1ITGAV
SCHEMBL4224698 0.76 ITGB3 (0.35) GRIA2ITGB3ITGB2ITGB1ITGAV
SCHEMBL6641445 0.72 GRIA2 (0.44) GRIA2KMT2A
SCHEMBL1849832 0.72 GRIA2 (0.44) GRIA2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0483429-A1 Biodegradable polymer compositions NOVA PHARMACEUTICAL CORPORATION (US) 1992-05-06 EP disclosed
US-4999417-A Drug carriers for controlled release NOVA PHARMACEUTICAL CORPORATION (US) 1991-03-12 US disclosed